112 related articles for article (PubMed ID: 10415778)
1. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease.
Kossakowska AE; Medlicott SA; Edwards DR; Guyn L; Stabbler AL; Sutherland LR; Urbanski SJ
Ann N Y Acad Sci; 1999 Jun; 878():578-80. PubMed ID: 10415778
[No Abstract] [Full Text] [Related]
2. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.
Jung K; Laube C; Lein M; Lichtinghagen R; Tschesche H; Schnorr D; Loening SA
Clin Chem; 1998 May; 44(5):1060-2. PubMed ID: 9590387
[No Abstract] [Full Text] [Related]
3. Analytical aspects regarding the measurement of metalloproteinases.
Lein M; Jung K; Nowak L; Schnorr D; Loening SA
Ann N Y Acad Sci; 1999 Jun; 878():491-3. PubMed ID: 10415751
[No Abstract] [Full Text] [Related]
4. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Iizasa T; Fujisawa T; Suzuki M; Motohashi S; Yasufuku K; Yasukawa T; Baba M; Shiba M
Clin Cancer Res; 1999 Jan; 5(1):149-53. PubMed ID: 9918213
[TBL] [Abstract][Full Text] [Related]
6. [Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications].
Stettner R; Bogusiewicz M; Rechberger T
Ginekol Pol; 2009 Jan; 80(1):47-53. PubMed ID: 19323060
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.
Walsh KM; Timms P; Campbell S; MacSween RN; Morris AJ
Dig Dis Sci; 1999 Mar; 44(3):624-30. PubMed ID: 10080160
[TBL] [Abstract][Full Text] [Related]
8. The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer.
Rauvala M; Turpeenniemi-Hujanen T; Puistola U
Anticancer Res; 2006; 26(6C):4779-84. PubMed ID: 17214341
[TBL] [Abstract][Full Text] [Related]
9. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
10. Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2.
Rossignol P; Jacob MP; Cambillau M; Mouradian D; Plouin PF; Chatellier G
Thromb Res; 2007; 119(2):261-3. PubMed ID: 16530811
[No Abstract] [Full Text] [Related]
11. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
[TBL] [Abstract][Full Text] [Related]
12. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.
Todor DR; Lewis I; Bruno G; Chyatte D
Stroke; 1998 Aug; 29(8):1580-3. PubMed ID: 9707196
[TBL] [Abstract][Full Text] [Related]
13. MMP-12 and TIMP Behavior in Symptomatic and Asymptomatic Critical Carotid Artery Stenosis.
Del Porto F; Cifani N; Proietta M; Toni D; Taurino M
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):334-338. PubMed ID: 27746079
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases and Their Inhibitors in Patients with Inguinal Hernia.
Isik A; Gursul C; Peker K; Aydın M; Fırat D; Yılmaz İ
World J Surg; 2017 May; 41(5):1259-1266. PubMed ID: 28050662
[TBL] [Abstract][Full Text] [Related]
15. Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
George DK; Ramm GA; Powell LW; Fletcher LM; Walker NI; Cowley LL; Crawford DH
Gut; 1998 May; 42(5):715-20. PubMed ID: 9659170
[TBL] [Abstract][Full Text] [Related]
16. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
17. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
[TBL] [Abstract][Full Text] [Related]
18. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
Fabunmi RP; Baker AH; Murray EJ; Booth RF; Newby AC
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
[TBL] [Abstract][Full Text] [Related]
19. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
